title: Does eltrombopag really ENABLE SVR?
authors.affiliation: Toronto Western Hospital Liver Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Aviva
authors.initials: A
authors.lastname: Leber
authors.affiliation: Toronto Western Hospital Liver Center, University Health Network, University of Toronto, Toronto, Ontario, Canada. Electronic address: Jordan.Feld@uhn.ca.
authors.forename: Jordan J
authors.initials: JJ
authors.lastname: Feld
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D006401:Hematologic Agents / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D011720:Pyrazoles / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000188:drug therapy*
chemical_list: D000998:Antiviral Agents; D001565:Benzoates; D006401:Hematologic Agents; D006834:Hydrazines; D011720:Pyrazoles; C520809:eltrombopag